MA. Melanie Dalaine DELA CRUZ CARNAJE, Jon Dave Torres Rebenque, Gary Antonio CENIDOZA LIRIO
{"title":"东南亚红树林物种的抗菌活性:系统综述","authors":"MA. Melanie Dalaine DELA CRUZ CARNAJE, Jon Dave Torres Rebenque, Gary Antonio CENIDOZA LIRIO","doi":"10.17576/jskm-2023-2102-08","DOIUrl":null,"url":null,"abstract":"Antimicrobial resistance in Southeast Asia is a macro-level health dilemma that may cause substantial casualties annually. Fortunately, Southeast Asian mangroves are potent reservoirs of bioactive compounds with antimicrobial properties in correlation to their traditional usage. Hence, this study aimed to systematically review studies concerning antimicrobial activities of mangroves in Southeast Asia as well as provide a technological overview of its prospective use in pharmaceutical industry applications through patents. Through the PRISMA protocol, the search for peer-reviewed studies originated from Southeast Asia and published between 2010 to 2022 were conducted over databases such as CORE, Google Scholar, PubMed (MedLine), Science Direct, Semantic Scholar, Scopus, and Web of Science. Additionally, a patent search was also performed on the Espacenet Patent Search, Google Patents, National Institute of Industrial Property, and United States Patent and Trademark Office. The studies and patents were collated on Mendeley Reference Manager as well as tabulated and assessed on Microsoft Office Excel 2016. After the four-phase screening, 59 studies and one patent regarding antimicrobial activities of Southeast Asian mangroves passed the criteria for the systematic review. It was inferred that Southeast Asia constitutes potentially most species-diverse mangroves with highly varied antimicrobial properties and can form synergism with drugs. The existing studies and patents may provide enlightenment on the future path of studies and inventions which must be continually substantiated in animal and clinical experiments for prospective pharmaceutical industry use. In this way, mangroves can be conserved while antimicrobial resistance and anthropogenic activities can be lowered.","PeriodicalId":17686,"journal":{"name":"Jurnal Sains Kesihatan Malaysia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antimicrobial Activities of Mangrove Species in Southeast Asia: A Systematic Review\",\"authors\":\"MA. Melanie Dalaine DELA CRUZ CARNAJE, Jon Dave Torres Rebenque, Gary Antonio CENIDOZA LIRIO\",\"doi\":\"10.17576/jskm-2023-2102-08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Antimicrobial resistance in Southeast Asia is a macro-level health dilemma that may cause substantial casualties annually. Fortunately, Southeast Asian mangroves are potent reservoirs of bioactive compounds with antimicrobial properties in correlation to their traditional usage. Hence, this study aimed to systematically review studies concerning antimicrobial activities of mangroves in Southeast Asia as well as provide a technological overview of its prospective use in pharmaceutical industry applications through patents. Through the PRISMA protocol, the search for peer-reviewed studies originated from Southeast Asia and published between 2010 to 2022 were conducted over databases such as CORE, Google Scholar, PubMed (MedLine), Science Direct, Semantic Scholar, Scopus, and Web of Science. Additionally, a patent search was also performed on the Espacenet Patent Search, Google Patents, National Institute of Industrial Property, and United States Patent and Trademark Office. The studies and patents were collated on Mendeley Reference Manager as well as tabulated and assessed on Microsoft Office Excel 2016. After the four-phase screening, 59 studies and one patent regarding antimicrobial activities of Southeast Asian mangroves passed the criteria for the systematic review. It was inferred that Southeast Asia constitutes potentially most species-diverse mangroves with highly varied antimicrobial properties and can form synergism with drugs. The existing studies and patents may provide enlightenment on the future path of studies and inventions which must be continually substantiated in animal and clinical experiments for prospective pharmaceutical industry use. In this way, mangroves can be conserved while antimicrobial resistance and anthropogenic activities can be lowered.\",\"PeriodicalId\":17686,\"journal\":{\"name\":\"Jurnal Sains Kesihatan Malaysia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Sains Kesihatan Malaysia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17576/jskm-2023-2102-08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Sains Kesihatan Malaysia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17576/jskm-2023-2102-08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
东南亚的抗微生物耐药性是一个宏观层面的健康困境,每年可能造成重大伤亡。幸运的是,东南亚红树林是具有抗菌特性的生物活性化合物的强大宿主,与它们的传统用途相关。因此,本研究旨在系统回顾东南亚红树林抗菌活性的研究,并通过专利提供其在制药行业应用的技术概述。通过PRISMA协议,在CORE、谷歌学者、PubMed(MedLine)、Science Direct、语义学者、Scopus和Web of Science等数据库上搜索来自东南亚并在2010年至2022年间发表的同行评审研究。此外,还对Espacnet专利搜索、谷歌专利、国家工业产权研究所和美国专利商标局进行了专利搜索。这些研究和专利在Mendeley Reference Manager上进行了整理,并在Microsoft Office Excel 2016上进行了列表和评估。经过四阶段筛选,59项关于东南亚红树林抗菌活性的研究和一项专利通过了系统审查标准。据推测,东南亚可能是种类最多的红树林,具有高度多样的抗菌特性,并可与药物形成协同作用。现有的研究和专利可能会为未来的研究和发明提供启示,这些研究和发明必须在动物和临床实验中不断得到证实,以供制药行业使用。通过这种方式,红树林可以得到保护,同时可以降低抗微生物耐药性和人类活动。
Antimicrobial Activities of Mangrove Species in Southeast Asia: A Systematic Review
Antimicrobial resistance in Southeast Asia is a macro-level health dilemma that may cause substantial casualties annually. Fortunately, Southeast Asian mangroves are potent reservoirs of bioactive compounds with antimicrobial properties in correlation to their traditional usage. Hence, this study aimed to systematically review studies concerning antimicrobial activities of mangroves in Southeast Asia as well as provide a technological overview of its prospective use in pharmaceutical industry applications through patents. Through the PRISMA protocol, the search for peer-reviewed studies originated from Southeast Asia and published between 2010 to 2022 were conducted over databases such as CORE, Google Scholar, PubMed (MedLine), Science Direct, Semantic Scholar, Scopus, and Web of Science. Additionally, a patent search was also performed on the Espacenet Patent Search, Google Patents, National Institute of Industrial Property, and United States Patent and Trademark Office. The studies and patents were collated on Mendeley Reference Manager as well as tabulated and assessed on Microsoft Office Excel 2016. After the four-phase screening, 59 studies and one patent regarding antimicrobial activities of Southeast Asian mangroves passed the criteria for the systematic review. It was inferred that Southeast Asia constitutes potentially most species-diverse mangroves with highly varied antimicrobial properties and can form synergism with drugs. The existing studies and patents may provide enlightenment on the future path of studies and inventions which must be continually substantiated in animal and clinical experiments for prospective pharmaceutical industry use. In this way, mangroves can be conserved while antimicrobial resistance and anthropogenic activities can be lowered.